Cancer Clinical Investigation

Search results

• New AI Tool by Mount Sinai Researchers Could Reshape Prostate Cancer Care

  Nair, S. & Tewari, A.

  23/09/24

  1 item of Media coverage

  Press/Media

• BostonGene and Mount Sinai Enter Collaboration

  Parekh, S. & Rodriguez, C.

  23/09/24

  1 item of Media coverage

  Press/Media

• Imaging study offers insights on mechanism behind BCG resistance in NMIBC

  Sfakianos, J.

  22/09/24

  1 item of Media coverage

  Press/Media

• US SECTOR WEEKLY: PRESS RELEASES OF LISTED COMPANIES IN THE BIOTECHNOLOGY SECTOR FRIDAY SEPTEMBER 20, 2024

  Marron, T.

  20/09/24

  1 item of Media coverage

  Press/Media

• Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024

  Llovet, J.

  19/09/24

  1 item of Media coverage

  Press/Media

• New Pembrolizumab Data Presented at ESMO Show Promise in a Variety of Cancers

  Llovet, J.

  19/09/24

  1 item of Media coverage

  Press/Media

• After I was diagnosed with Merkel cell carcinoma, I discovered how a band of physician-scientists triggered a revolution

  Bhardwaj, N.

  18/09/24

  1 item of Media coverage

  Press/Media

• Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

  Parekh, S. & Onel, K.

  18/09/24

  3 items of Media coverage

  Press/Media

• Alligator Bioscience and Aptevo Therapeutics Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study

  Marron, T.

  18/09/24

  1 item of Media coverage

  Press/Media

• Phase 3 LEAP-012 Trial Offers A New Option for Intermediate-Stage HCC Management

  Llovet, J.

  17/09/24

  1 item of Media coverage

  Press/Media

• LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Combination With Transarterial Chemoembolization (TACE) Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma

  Llovet, J.

  17/09/24

  1 item of Media coverage

  Press/Media

• LENVIMA(R) (Lenvatinib) Plus KEYTRUDA(R) (Pembrolizumab) In Combination With Transarterial Chemoembolization (TACE) Significantly Improved Progression-Free Survival Compared To TACE Alone In Patients With Unresectable, Non-Metastatic Hepatocellular Carcin

  Llovet, J.

  16/09/24 → 17/09/24

  6 items of Media coverage

  Press/Media

• Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

  Parekh, S. & Onel, K.

  17/09/24

  70 items of Media coverage

  Press/Media

• Inherited changes in BRCA genes linked to increased risk of multiple myeloma

  Parekh, S. & Onel, K.

  17/09/24

  1 item of Media coverage

  Press/Media

• New Breast Cancer Study Findings Recently Were Reported by Researchers at Indiana University (Ecog-acrin Eaz171: Prospective Validation Trial of Germline Predictors of Taxane-induced Peripheral Neuropathy In Black Women With Early-stage Breast ...)

  Sparano, J.

  17/09/24

  1 item of Media coverage

  Press/Media

• part 1: KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved

  Llovet, J.

  16/09/24

  1 item of Media coverage

  Press/Media

• Another Possible Treatment Option for Intermediate-Stage Liver Cancer

  Llovet, J.

  16/09/24

  1 item of Media coverage

  Press/Media

• KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma

  Llovet, J.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study

  Marron, T.

  16/09/24

  16 items of Media coverage

  Press/Media

• Mount Sinai Launches Center of Excellence to Enhance Treatment and Care for Patients With Gynecologic Cancer

  Blank, S.

  16/09/24

  1 item of Media coverage

  Press/Media

• 08:26 EDT Aptevo, Alligator Bioscience announce data from Phase 1 ALG.APV-527 trial

  Marron, T.

  16/09/24

  1 item of Media coverage

  Press/Media

• Aptevo and Alligator report promising trial results for cancer drug

  Marron, T.

  16/09/24

  1 item of Media coverage

  Press/Media

• How the aging immune system fuels cancer growth

  Merad, M. & Marron, T.

  16/09/24

  1 item of Media coverage

  Press/Media

• Lenvatinib, Pembrolizumab Plus TACE Improves PFS in Intermediate-Stage HCC

  Llovet, J.

  15/09/24

  1 item of Media coverage

  Press/Media